15 matches for your search in the start-up spotlight
rssRefoxy is the first biotech company purposely developing FOXO3 activators to leverage the therapeutic effects related to this master regulator of biological homeostasis. Refoxy’s discovery platform, F.act finder (FOXO activator finder), delivers molecules that specifically modulate FOXO3 and ...
Society is facing unprecedented health and economic burdens associated with aging. Worldwide population is rapidly becoming older and living more unhealthy years. The fact we treat diseases individually is contributing to the increase in the incidence of age-related diseases. Booster aims to ...
We develop advanced regenerative stem cell therapies to fight the devastating consequences of muscle diseases.
DEMECAN is a medicinal cannabis company focusing on the cultivation, importation and wholesale of medicinal cannabis.
T-knife was founded in 2018 by Thomas Blankenstein, Elisa Kieback and Holger Specht as spin-off from Max-Delbruck Center for Molecular Medicine with support of Charité University Hospital in Berlin/Germany and the mission to bring novel, sophisticated T cell receptor-based therapeutics to market. ...
PerformaNat develops novel feed additives for improved animal health with a focus on prevention of gastrointestinal diseases and metabolic disorders as well as boosting the immune system. PerformaNat’s competitive advantage is based on a unique technology platform for identification and ...
moloX GmbH was founded 2012 in Berlin, Germany by Dr. Holger von Moeller and Dr. Bernhard Loll. The company is exclusively owned by its founders and does not rely on any external funding reflecting its reliability, quality and ease of relationship with clients. moloX aims at providing customers ...
Tubulis Technologies is currently a pre-start-up project affiliated with the Ludwig Maximilians University (LMU) Munich and the Leibniz-Institut für Molekulare Pharmakologie (FMP) Berlin. Tubulis Technologies aims to provide the next generation of highly defined, effective and stable ADCs. The ...